Kester Capital is a leading UK mid-market private equity firm.
Business Model:
Revenue: $0
Employees: 0-0
Address: 48 Dover Street
City: London
State: england
Zip: W1S 4FF
Country: GB
Kester Capital is a leading UK mid-market private equity firm. It was established in 2007 as Greenhill Capital Partners Europe (“GCP Europe”), the European private equity arm of Greenhill &a; Co Inc. Kester Capital is managed by a team of experienced professionals and invests on behalf of a number of blue chip institutional investors. Kester Capital is currently investing its second fund, which was raised in 2013. Kester Capital&s;s target equity investment size is £5 – 25 million.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
12/2006 | Xanthus Pharmaceuticals | Series B | 0 |
2/2021 | Optibrium | Private Equity Round | - |
6/2016 | Avania | Private Equity Round | - |
9/2007 | Ironshore Insurance | Private Equity Round | - |
1/2011 | Industry Dynamics | Private Equity Round | - |
1/2010 | Chiltern International | Private Equity Round | - |
6/2022 | Optibrium | Private Equity Round | - |
1/2008 | Travel Entertainment Group, Ltd. | Private Equity Round | - |
12/2013 | Frontier Medical Group | Private Equity Round | - |
6/2022 | Optibrium | Private Equity Round | - |
2/2021 | Optibrium | Private Equity Round | - |
6/2016 | Avania | Private Equity Round | - |
12/2013 | Frontier Medical Group | Private Equity Round | - |
1/2011 | Industry Dynamics | Private Equity Round | - |
1/2010 | Chiltern International | Private Equity Round | - |
1/2008 | Travel Entertainment Group, Ltd. | Private Equity Round | - |
9/2007 | Ironshore Insurance | Private Equity Round | - |
12/2006 | Xanthus Pharmaceuticals | Series B | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|